{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T21:27:08Z","timestamp":1774128428711,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1124\/jpet.114.221002","type":"journal-article","created":{"date-parts":[[2015,1,24]],"date-time":"2015-01-24T04:13:43Z","timestamp":1422072823000},"page":"27-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Cholesteryl Ester-Transfer Protein Inhibitors Stimulate Aldosterone Biosynthesis in Adipocytes through Nox-Dependent Processes"],"prefix":"10.1016","volume":"353","author":[{"given":"Francisco J.","family":"Rios","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karla B.","family":"Neves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurelie","family":"Nguyen Dinh Cat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Even","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Palacios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Augusto C.","family":"Montezano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0670-0887","authenticated-orcid":false,"given":"Rhian M.","family":"Touyz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.114.221002_bib1","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0140-6736(10)61853-3","article-title":"Monitoring and surveillance of chronic non-communicable diseases: progress and capacity in high-burden countries","volume":"376","author":"Alwan","year":"2010","journal-title":"Lancet"},{"key":"10.1124\/jpet.114.221002_bib2","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1161\/01.ATV.0000054658.91146.64","article-title":"Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis","volume":"23","author":"Barter","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/jpet.114.221002_bib3","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa0706628","article-title":"Effects of torcetrapib in patients at high risk for coronary events","volume":"357","author":"Barter","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.114.221002_bib4","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1161\/HYPERTENSIONAHA.111.190223","article-title":"Adipocytes produce aldosterone through calcineurin-dependent signaling pathways: implications in diabetes mellitus-associated obesity and vascular dysfunction","volume":"59","author":"Briones","year":"2012","journal-title":"Hypertension"},{"key":"10.1124\/jpet.114.221002_bib5","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jash.2011.02.001","article-title":"Differential regulation of Nox1, Nox2 and Nox4 in vascular smooth muscle cells from WKY and SHR","volume":"5","author":"Briones","year":"2011","journal-title":"J Am Soc Hypertens"},{"key":"10.1124\/jpet.114.221002_bib6","doi-asserted-by":"crossref","first-page":"e1000938","DOI":"10.1371\/journal.pcbi.1000938","article-title":"Drug off-target effects predicted using structural analysis in the context of a metabolic network model","volume":"6","author":"Chang","year":"2010","journal-title":"PLOS Comput Biol"},{"key":"10.1124\/jpet.114.221002_bib7","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1124\/dmd.108.023176","article-title":"Pharmacokinetics, metabolism, and excretion of torcetrapib, a cholesteryl ester transfer protein inhibitor, in humans","volume":"36","author":"Dalvie","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.114.221002_bib8","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1038\/bjp.2008.229","article-title":"Torcetrapib-induced blood pressure elevation is independent of CETP inhibition and is accompanied by increased circulating levels of aldosterone","volume":"154","author":"Forrest","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.114.221002_bib9","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1161\/HYPERTENSIONAHA.109.146936","article-title":"Aldosterone, sodium, and hypertension: lessons from torcetrapib?","volume":"55","author":"Funder","year":"2010","journal-title":"Hypertension"},{"key":"10.1124\/jpet.114.221002_bib10","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0002-9343(77)90874-9","article-title":"High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study","volume":"62","author":"Gordon","year":"1977","journal-title":"Am J Med"},{"key":"10.1124\/jpet.114.221002_bib11","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.amjcard.2013.08.041","article-title":"Evaluation of lipids, drug concentration, and safety parameters following cessation of treatment with the cholesteryl ester transfer protein inhibitor anacetrapib in patients with or at high risk for coronary heart disease","volume":"113","author":"Gotto","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1124\/jpet.114.221002_bib12","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.mce.2011.07.034","article-title":"Acute and chronic regulation of aldosterone production","volume":"350","author":"Hattangady","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"10.1124\/jpet.114.221002_bib13","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1210\/en.2008-1512","article-title":"Torcetrapib induces aldosterone and cortisol production by an intracellular calcium-mediated mechanism independently of cholesteryl ester transfer protein inhibition","volume":"150","author":"Hu","year":"2009","journal-title":"Endocrinology"},{"key":"10.1124\/jpet.114.221002_bib14","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1056\/NEJM199011013231803","article-title":"Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation","volume":"323","author":"Inazu","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.114.221002_bib15","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2165\/11599310-000000000-00000","article-title":"On- and off-target pharmacology of torcetrapib: current understanding and implications for the structure activity relationships (SAR), discovery and development of cholesteryl ester-transfer protein (CETP) inhibitors","volume":"72","author":"Johns","year":"2012","journal-title":"Drugs"},{"key":"10.1124\/jpet.114.221002_bib16","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/ncpcardio1191","article-title":"Spotlight on HDL-raising therapies: insights from the torcetrapib trials","volume":"5","author":"Kontush","year":"2008","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"10.1124\/jpet.114.221002_bib17","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1124\/jpet.114.221002_bib18","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1161\/CIRCRESAHA.114.300935","article-title":"High-density lipoprotein: vascular protective effects, dysfunction, and potential as therapeutic target","volume":"114","author":"L\u00fcscher","year":"2014","journal-title":"Circ Res"},{"key":"10.1124\/jpet.114.221002_bib19","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0140-6736(75)92376-4","article-title":"Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease","volume":"1","author":"Miller","year":"1975","journal-title":"Lancet"},{"key":"10.1124\/jpet.114.221002_bib20","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1089\/ars.2011.4176","article-title":"NADPH oxidase-derived H(2)O(2) contributes to angiotensin II-induced aldosterone synthesisin human and rat adrenal cortical cells","volume":"17","author":"Rajamohan","year":"2012","journal-title":"Antioxid Redox Signal"},{"key":"10.1124\/jpet.114.221002_bib21","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/CRD.0000000000000023","article-title":"Anacetrapib: a potential new therapy for dyslipidemia","volume":"22","author":"Robinson","year":"2014","journal-title":"Cardiol Rev"},{"key":"10.1124\/jpet.114.221002_bib22","doi-asserted-by":"crossref","first-page":"3C","DOI":"10.1016\/0002-9149(86)91020-9","article-title":"Atherosclerosis and lipoprotein metabolism: role of reverse cholesterol transport","volume":"57","author":"Roheim","year":"1986","journal-title":"Am J Cardiol"},{"key":"10.1124\/jpet.114.221002_bib23","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa1206797","article-title":"Effects of dalcetrapib in patients with a recent acute coronary syndrome","volume":"367","author":"Schwartz","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.114.221002_bib24","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1677\/JME-08-0167","article-title":"Short term regulation of aldosterone secretion after stimulation and suppression experiments in mice","volume":"42","author":"Spyroglou","year":"2009","journal-title":"J Mol Endocrinol"},{"key":"10.1124\/jpet.114.221002_bib25","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0022-2275(20)38819-2","article-title":"Plasma lipid transfer proteins","volume":"27","author":"Tall","year":"1986","journal-title":"J Lipid Res"},{"key":"10.1124\/jpet.114.221002_bib26","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(12)60312-2","article-title":"Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study","volume":"380","author":"Voight","year":"2012","journal-title":"Lancet"},{"key":"10.1124\/jpet.114.221002_bib27","doi-asserted-by":"crossref","first-page":"e1000387","DOI":"10.1371\/journal.pcbi.1000387","article-title":"Drug discovery using chemical systems biology: identification of the protein-ligand binding network to explain the side effects of CETP inhibitors","volume":"5","author":"Xie","year":"2009","journal-title":"PLOS Comput Biol"},{"key":"10.1124\/jpet.114.221002_bib28","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/jcb.22936","article-title":"JAK2\/STAT3 pathway is involved in the early stage of adipogenesis through regulating C\/EBP\u03b2 transcription","volume":"112","author":"Zhang","year":"2011","journal-title":"J Cell Biochem"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652418980X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652418980X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.114.221002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T17:58:06Z","timestamp":1739987886000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235652418980X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S002235652418980X"],"URL":"https:\/\/doi.org\/10.1124\/jpet.114.221002","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cholesteryl Ester-Transfer Protein Inhibitors Stimulate Aldosterone Biosynthesis in Adipocytes through Nox-Dependent Processes","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.114.221002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}